You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:55:22 UTC
Last Updated2019-10-01 21:42:15 UTC
CypComp IDCC02487
Compound Information
NameRupatadine
Structure ImageWuzykbabmwjhdl uhfffaoysa n
InChIKeyWUZYKBABMWJHDL-UHFFFAOYSA-N
PubChem ID133017
CypCompound Information
SetCypBoM Testing Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <7,8;Cleavage;R1>
  • <7,H;Oxidation;R1>
References
  1. Taubel J, Ferber G, Fernandes S, Lorch U, Santamaria E, Izquierdo I: Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial. PLoS One. 2016 Sep 15;11(9):e0163020. doi: 10.1371/journal.pone.0163020. eCollection 2016. [PubMed:27632557 ]
  2. Pharmacorama (2010) Rupatadine, Wystamm, H1 Antihistamine [French] [Link]
Download FileCC02487.sdf